Related Experiment Video
Updated: May 13, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
BRCA-associated pancreatic cancer: the evolving management
Keith Leung1, Muhammad Wasif Saif
1Division of Hematology/Oncology, Department of Medicine and Cancer Center, Tufts Medical Center, Boston, MA 02111, USA.
JOP : Journal of the Pancreas
|March 12, 2013
Summary
BRCA-associated pancreatic cancer shows promise with PARP inhibitors, but platinum chemotherapy offers no benefit. These findings are shaping treatment strategies for this rare but aggressive cancer.
Area of Science:
- Oncology
- Genetics
Background:
- Pancreatic cancer is a highly lethal malignancy.
- BRCA-associated pancreatic cancers, though uncommon, present unique therapeutic opportunities.
- Understanding treatment responses in BRCA-mutated pancreatic cancer is crucial.
Purpose of the Study:
- To review the characteristics and outcomes of BRCA-associated pancreatic cancer.
- To evaluate the efficacy of platinum chemotherapy and PARP inhibitors in this patient group.
- To synthesize current knowledge and new findings on treating BRCA-associated pancreatic cancer.
Main Methods:
- Review of case series presented at the 2013 ASCO Gastrointestinal Cancers Symposium.
- Analysis of studies investigating platinum chemotherapy and poly-(ADP-ribose) polymerase (PARP) inhibitors.
- Synthesis of existing literature on BRCA-associated pancreatic cancer treatment.
Main Results:
- A large case series did not demonstrate a benefit of first-line platinum chemotherapy for advanced pancreatic cancer.
- Substantial responses were observed in BRCA2-associated pancreatic cancer patients treated with the PARP inhibitor ABT-888 (veliparib).
Conclusions:
- First-line platinum chemotherapy is not beneficial for advanced pancreatic cancer.
- PARP inhibitors show promise for treating BRCA2-associated pancreatic cancer.
- New therapeutic strategies are emerging for BRCA-associated pancreatic cancer based on these findings.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...